|
|
|
| () | |
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
on May 09, 2008 by Don Dion
-
Monday's Options Report: BSC, LEH, XLF, ACAS, VIX, CFC, CVTX
on Mar 10, 2008 by Andrew Wilkinson
-
Loeb's Third Point Issues Latest 13F: Summary of Holdings
on Aug 16, 2007 by Lon Juricic
-
CV Therapeutics Takeover Speculation Overshadows Earnings News
on Aug 01, 2007 by Word on the Street
-
Earnings Preview: Five Companies That Could Surprise
on Jul 30, 2007 by Zacks.com
-
CV Therapeutics Takes Off Right Out of Gate On Takeover Talk
on Jun 21, 2007 by Word on the Street
-
A CV Therapeutics Sale? Premature But Not Far Fetched
on Jun 20, 2007 by Word on the Street
-
Pendulum Beginning To Swing In CV Therapeutics' Favor
on Jun 19, 2007 by Word on the Street
-
Screening for Potential Buyout Targets
on Jun 05, 2007 by Mark Hines
-
CV Therapeutics: Loeb's Third Point Discloses 9.9% Stake
on May 18, 2007 by Lon Juricic
-
Loeb's Third Point Releases 13F Filing, Shows a Number of New Positions
on May 17, 2007 by Lon Juricic
-
CV Therapeutics: 'High Chance' of Regadenoson Approval Sends Shares Higher
on May 16, 2007 by Word on the Street
-
The Next Great Biotech Short Squeeze
on Apr 23, 2007 by Andrew Vaino
-
Biotech Day In Review: Regeneron Up On AMD Data
on Mar 28, 2007
-
CV Therapeutics Shares Reverse Course on Positive American College of Cardiology Meetings
on Mar 27, 2007 by Word on the Street
-
Why the CV Therapeutics Sell-off Was Overdone
on Mar 09, 2007 by Jason Shade
-
Ranexa Won't Treat Heart Attacks, CV Therapeutics Falls 24%
on Mar 08, 2007 by SA Editor Judy Weil
-
Biotech Day in Review: Avalon Signs $200 Million Deal with Merck
on Mar 08, 2007 by Centient Biotech Investor
-
CV Therapeutics Trial Results: Enough To Drive Profitability?
on Mar 07, 2007 by Notable Calls
-
Will MERLIN Work Magic For CV Therapeutics?
on Feb 06, 2007 by Jason Shade
-
CV Therapeutics: Last Chance for a Tax Loss
on Dec 29, 2006 by Travis Johnson
-
Biotech Portfolio Overview: PDL Biopharm Still Cheap, CV Therapeutics Still Falling
on Aug 06, 2006 by Travis Johnson
-
Biotech Bloodletting: CV Therapeutics and Vertex Pharmaceuticals (CVTX, VRTX)
on Apr 26, 2006 by Travis Johnson
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email